---
title: Chronic eosinophilic leukemia with a novel JAK1 mutation responds well to the
  JAK1/2 inhibitor ruxolitinib
date: '2024-07-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38990537/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240711181424&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...